ANN ARBOR, Mich.--(BUSINESS WIRE)--Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS™), under development by Hygieia, Inc., demonstrate DIGS’ potential to ...

The US Food and Drug Administration has cleared new decision-support software that aids in insulin dosing. In addition, Insulin Algorithms is "an affordable, easily adoptable tool for every-size ...

Glycemic control outcomes were similar between patients with type 2 diabetes who received insulin titration on the basis of an AI-assisted system vs a physician. Real-time artificial intelligence (AI) ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

Diabetes, affecting millions worldwide, poses a significant challenge to the healthcare system due to the complexity of therapy and difficulty to adequately control the disease. Particularly, patients ...

It is estimated that approximately 25%–30% of hospitalized adults have diabetes. Numerous studies have demonstrated the benefits of technological advances such as continuous glucose monitoring (CGM) ...

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type 2 diabetes. About 99% of AI-based insulin recommendations were adopted by ...

Sliding scale insulin therapy uses your pre-meal blood sugar level to determine insulin dosage. Research indicates sliding scale insulin therapy is ineffective at managing blood sugar levels.

Inhaled insulin uptake has been slow since its FDA approval due in part to a lack of awareness among adults with diabetes. The ongoing INHALE-1 study may help inhaled insulin earn FDA approval for ...